full free access: The Role of In Vitro Directed Chemotherapy in Epithelial Ovarian Cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, September 20, 2010

full free access: The Role of In Vitro Directed Chemotherapy in Epithelial Ovarian Cancer



Epithelial ovarian cancer (EOC) continues to be the most lethal gynecologic malignancy. Efforts to personalize chemotherapy treatments by utilizing in vitro tumor assays to predict chemotherapeutic response have been tested in both the primary and recurrent treatment setting. To date, several retrospective studies have suggested improved response rates to predicted chemotherapeutic agents. However, a prospective, controlled trial merely found equivalence between in vitro prediction and empirical treatment selection. This review summarizes the current data regarding in vitro directed chemotherapy in EOC.

Conclusions: In vitro chemotherapy sensitivity and resistance testing may still hold promise for clinical decision-making, improved survival, and limiting unnecessary toxicity in the treatment of EOC. Given the current limitations and lack of randomized, controlled results, these assays are best used in the setting of a clinical trial.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.